Article
No evidence for genomic imprinting in liveborn Down syndrome patients.
Annales de genetique - 1 Jan 1995
Stoll C, Alembik Y, Dott B, Feingold J
Abstract excerpt
Despite numerous studies, the clinical heterogeneity of Down syndrome has no explanation. The authors have attempted to investigate the role of genomic imprinting in the phenotype of liveborn Down syndrome patients. Hundred fifty eight patients were investigated for parental origin of the extra chromosome 21 with standard cytogenetic analyses and with DNA polymorphic markers. The extra chromosome 21 was of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.